The loss of METTL3 and METTL14 complexes can upregulate the expression of AKT pathway members and lead to increased cell proliferation, which in turn exhibits tumor suppressor functions in endometrial cancer [162]. The gene discussed is METTL14; the disease is endometrial cancer.